We are live on ! Find out more
CSII

Cardiovascular Systems, Inc.

Delisted

CSII was delisted on the 27th of April, 2023.

150 hedge funds and large institutions have $767M invested in Cardiovascular Systems, Inc. in 2023 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 35 increasing their positions, 56 reducing their positions, and 48 closing their positions.

New
Increased
Maintained
Reduced
Closed

56% more capital invested

Capital invested by funds: $491M → $767M (+$276M)

7% less funds holding

Funds holding: 161150 (-11)

19% less first-time investments, than exits

New positions opened: 39 | Existing positions closed: 48

38% less repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 56

53% less call options, than puts

Call options by funds: $2.63M | Put options by funds: $5.66M

Holders
150
Holders Change
-11
Holders Change %
-6.83%
% of All Funds
2.39%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
39
Increased
35
Reduced
56
Closed
48
Calls
$2.63M
Puts
$5.66M
Net Calls
-$3.02M
Net Calls Change
-$2.87M

CSII Hedge Fund Activity: Q1 2023 in Review

150 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Cardiovascular Systems, Inc. (CSII) for Q1 2023, worth a combined $767M — up 56% from $491M a quarter earlier.

Sellers outnumbered buyers: 48 funds closed out of CSII and 39 opened new positions — a net loss of 9 holders — while 56 trimmed existing stakes and 35 added.

The largest buyer was Pentwater Capital Management, opening a new position worth an estimated $30.1M. The largest seller was Camber Capital Management, exiting entirely with an estimated $17.7M sold.

  • 150 institutional investors held Cardiovascular Systems, Inc. (CSII) as of Q1 2023, down from 161 in Q4 2022.
  • Funds reported $767M of Cardiovascular Systems, Inc. stock for Q1 2023, up 56% quarter-over-quarter.
  • 39 funds opened new Cardiovascular Systems, Inc. positions in Q1 2023 and 48 closed out, a net change of -9 holders.
  • The largest Cardiovascular Systems, Inc. buyer in Q1 2023 was Pentwater Capital Management, an estimated $30.1M added.
  • The largest Cardiovascular Systems, Inc. seller in Q1 2023 was Camber Capital Management, an estimated $17.7M sold.

Based on aggregated 13F filings for Q1 2023.